Romero-Haro AA, Figuerola J, Alonso-Alvarez C
24-month real-time and 6-month accelerated (40C/75% RH) stability reports provided
However, patches present their own adherence challenges, including skin irritation, adhesion problems, and the need for regular application site rotation
revealed that adding atorvastatin (20 mg/day, P.O for 4 weeks) reduced plasma MDA while improving the functional capacity assessed via a 6-minute walk test in patients with chronic heart failure (CHD) [228]
Hydrophobic peptides require different handling than highly charged or amphipathic sequences
Therapeutic Goods Administration issues safety alert amid explosion of illegal peptide use Tue 14 Apr 2026 at 11:14am , updated Tue 14 Apr 2026 at 11:45am In short: The medicines regulator has issued a health alert about the risks of using unregulated peptides amid a surge in the use of potentially unsafe injectables